What is the suggested antithrombotic therapy for AF patients requiring OAC presenting with an ACS, undergoing PCI/stenting with high bleeding risk?
We suggest triple therapy for 1-3 months, followed by dual therapy with OAC plus single antiplatelet (preferably clopidogrel) up to 12 months, following which OAC monotherapy can be used (Weak recommendation, low quality evidence).